The α-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: A new class of inflammatory apolipoprotein and a possible contributor to atherogenesis

Blood

Volumn 96, Issue 4, 2000, Pages 1393-1398

  Higazi, A A R ^a   Nassar, T ^a   Ganz, T ^a   Rader, D J ^a   Udassin, R ^a   Bdeir, K ^a   Hiss, E ^a   Sachais, B S ^a   Williams, K J ^a   Leitersdorf, E ^a   Cines, D B ^a  

^a Laboratory Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; DEFENSIN; HEPARIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SYNDECAN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL; ENDOCYTOSIS; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; LIPOLYSIS; LIPOPROTEIN METABOLISM; MEMBRANE BINDING; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PROTEINS; CHO CELLS; CRICETINAE; DEFENSINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; NEUTROPHILS; PROTEINS; PROTEOGLYCANS; RECEPTORS, LDL;

EID: 0034663030     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL
2. A receptor-mediated pathway for cholesterol homeostasis
3. Expression cloning of a novel scavenger receptor from human endothelial cells
4. Familial defective apolipoprotein B-110: Low density lipoproteins with abnormal receptor binding
5. A novel point mutation (Pro84→Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia
6. The response-to-retention hypothesis of early atherogenesis
7. Lipoprotein trafficking in vascular cells: Molecular Trojan horses and cellular saboteurs
8. Atherosclerosis: An inflammatory disease
9. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
10. Virus in the etiology of atherosclerosis
11. Past infection by Chlamydiae pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
12. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis
13. Chlamydia in coronary plaques: Hidden culprit or harmless hobo?
14. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
15. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow
16. Learning from the transgenic mouse: Endothelium, adhesive molecules, and neointima formation
17. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
18. Lipoprotein (a) and coronary heart disease risk: A nested case control study of the Helsinki Heart Study participants
19. The leukocyte count as a predictor of myocardial infarction
20. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men
21. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes
22. Primary structures of three human neutrophil defensins
23. Crystal structure of defensin HNP-3, an amphiphilic dimer: Mechanisms of membrane permeabilization
24. Neutrophil defensins: Purification, characterization, and antimicrobial testing
25. Plasma defensin concentrations are elevated in patients with sepsis or bacterial meningitis
26. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infection
27. Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis
28. Degradation of connective tissue matrices by macrophages, I: Proteolysis of elastin, glycoproteins, and collagen by proteases isolated from macrophages
29. The α(1,3)fucosyltranferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis
30. Defensin stimulates the binding of Lp(a) to human vascular endothelial and smooth muscle cells
31. Defensin promotes the binding of lipoprotein(a) to vascular matrix
32. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils
33. Defensin modulates tPA and plasminogen binding to fibrin and endothelial cells
34. Immunohistochemical localization of defensin in human corenary vessels
35. Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein
36. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins
37. Identification of the principal proteoglycan binding site in LDL. A single point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding
38. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor
39. Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix
40. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins
41. The metabolism of very low density lipoprotein proteins, I: Preliminary in vitro and in vivo observations
42. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
43. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation
44. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors
45. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells
46. Hypercholesterolemia in five Israeli Christian-Arab kindreds is caused by the 'Lebanese' allele at the low density lipoprotein receptor gene locus and by an additional independent major factor
47. Genetic analysis of proteoglycan structure, function and metabolism
48. The syndecan family of proteoglycans: Novel receptors mediating internalization of atherogenic lipoproteins in vitro
49. Interaction of single chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins
50. Endocytosis of urokinase-plasminogen activator inhibitor type I complexes bound to a chimeric transmembrane urokinase inhibitor
51. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins
52. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
53. Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans
54. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: Roles for low density lipoprotein receptors and heparan sulfate proteoglycans
55. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans: Apolipoproteins E3 and E2 greater than E4